Larvol Delta - Bionyra-Pharmaannounced-that-the-rst-healthy-volunteers-have-been-dosed-in-the-Phase-1-study-of-BYN001-the-company39s-longacting-antiIL25-monoclonal-antibody-being-developed-for-atopic-dermatitis

BYN-001 - Bionyra Pharma

https://www.businesswire.com/news/home/20260910634262/en/Bionyra-Pharma-Announces-First-Healthy-Volunteers-Dosed-in-Phase-1-Study-of-BYN-001-a-Long-Acting-IL-25-Antibody-for-Atopic-Dermatitis

Sep 10, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Next